Catherine Larue
Chief Executive Officer
Pathology
IBBL
Luxembourg
Biography
Larue was appointed as IBBL’s Chief Executive Officer (CEO) in November 2012. She has over 20 years of experience in research and development of in vitro diagnostics. In addition, she has held leadership roles in biopharmaceutical companies focused on translational research and personalized medicine for the past 10 years. After a Ph.D. in Immunology, Catherine Larue began her career at Sanofi, Montpellier (France) in the cardiovascular R&D department and participated in the discovery of innovative biomarkers such as troponin I and natriuretic peptides.
Research Interest
Personalized medicine
